Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Sales | 1,080 | 0 |
| Cost of Goods | 17,867 | N/A |
| Gross Profit | -16,787 | N/A |
| Operating Expenses | 4,563 | 0 |
| Operating Income | -20,483 | N/A |
| Interest Expense | 196 | 0 |
| Other Income | 2,380 | 0 |
| Pre-tax Income | -18,299 | 0 |
| Net Income Continuous | -18,299 | N/A |
| Net Income | $-18,299 | $N/A |
| EPS Basic Total Ops | -0.63 | N/A |
| EPS Basic Continuous Ops | -0.63 | N/A |
| EPS Diluted Total Ops | -0.63 | N/A |
| EPS Diluted Continuous Ops | -0.63 | N/A |
| EBITDA(a) | $-19,754 | $N/A |